Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05091983
Other study ID # APHP211140
Secondary ID 2021-A01755-36
Status Completed
Phase
First received
Last updated
Start date November 30, 2021
Est. completion date March 24, 2022

Study information

Verified date June 2022
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study offers to determine whether adolescent patients with a restrictive eating disorder have variations in their sensoriality compared to a control group.


Description:

Eating disorders are a frequent reason for consultation in pediatrics at all ages. When they are small, children may have an orality disorder. There are multiple potential causes for this disorder: psychogenic, oropraxic but also sensory. The treatment is then adapted to the patient, with, among other things, an orientation towards professionals trained in sensory disorders. As they grow up, adolescents are particularly at risk of developing eating disorders, which are pathologies that correspond to a biopsychosocial model of understanding that includes psychogenetic, neuroendocrine and immune factors. Despite major advances in the understanding of this disease, the sensory dimension for these patients is still little studied and is not taken into account in the treatment proposed to adolescents suffering from eating disorders.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date March 24, 2022
Est. primary completion date March 24, 2022
Accepts healthy volunteers No
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria: - Adolescent between 12 to 18 years old. - Non-opposition of the adolescent and his or her legal guardians collected before the start of the study. - Patient group: Diagnosis of restrictive eating disorders (Anorexia Nervosa typical or atypical, ARFID) meeting DSM-5 criteria. - Control group: absence of eating disorders. Exclusion Criteria: - Eating disorders secondary to another psychiatric pathology. - Precarious health status with somatic and/or psychiatric instability that does not allow to answer the questionnaire. - Language barrier. - Opposition of the adolescent and/or his/her legal representatives obtained before the start of the study - Patient under " AME " (medical state help)

Study Design


Intervention

Other:
Sensory Processing Scale Inventory (SPSI)
The Sensory Processing Scale Inventory (SPSI) is the main questionnaire. It allows to define over and under sensitive profiles. It's a self-administrated questionnaire
Autism Spectrum Screening Quotient (ASSQ)
The ASSQ allows to detect autism spectrum disorders (ASD). This quotient is proposed to the group because the investigators know that ASD are often correlated with sensory integration disorders. It's answered by the participant's parents.
GAD 7
The GAD7 questionnaire allows to detect anxiety disorder. This questionnaire is proposed to the group because the investigators know that anxiety disorders are often correlated with sensory integration disorders. It's a self-administrated questionnaire.
Conners abridged
The Conners abridged questionnaire allows to detect attention-deficit hyperactivity disorder (ADHD). This questionnaire is proposed to the group because the investigators know that ADHD are often correlated with sensory integration disorders. The questionnaire is answered by the participant's parents.
EAT 26
The EAT 26 questionnaire allows to detect anorexia nervosa. It is proposed to the patient with an eating disorder to establish the level of severity of their disease. It's a self-administrated questionnaire.

Locations

Country Name City State
France Maison de Solenn Maison des Adolescents, Cochin Hospital Paris IDF

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (3)

Battle DE. Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas. 2013;25(2):191-2. — View Citation

Gorwood P, Blanchet-Collet C, Chartrel N, Duclos J, Dechelotte P, Hanachi M, Fetissov S, Godart N, Melchior JC, Ramoz N, Rovere-Jovene C, Tolle V, Viltart O, Epelbaum J. New Insights in Anorexia Nervosa. Front Neurosci. 2016 Jun 29;10:256. doi: 10.3389/fnins.2016.00256. eCollection 2016. Review. — View Citation

Schoen SA, Miller LJ, Green KE. Pilot study of the Sensory Over-Responsivity Scales: assessment and inventory. Am J Occup Ther. 2008 Jul-Aug;62(4):393-406. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Average Sensory Processing Scale Inventory (SPSI) scores between the two groups Comparison of average Sensory Processing Scale Inventory (SPSI) scores between the two groups This questionnaire focuses on sensoriality. It allows the definition of over or under-reactive sensory profiles. It is made of two lists (list #1 : 73 items ; list #2 : 29 items).
The SPSI questionnaire is in English. For this reason, a group of experts from La Maison de Solenn met to translate it into French being as faithful as possible to the original questionnaire. Each checklist has its own score, the result is the sum of the points obtained (one point for YES, zero points for NO) (6).
Two groups will be formed: a group with eating disorders and a control group. The questionnaire will be answered only once and will be proposed to the participant at the end of a consultation at the Maison de Solenn for his usual follow-up or during a hospitalization (full time hospitalization or in day hospital).
Inclusion
Secondary Screening for pathologies known to be associated with a sensory disorder Screening questionnaires for Autism Spectrum Disorder (ASD) will be distributed in order to identify disorders associated with a particular sensory profile. This will allow statistical results to be refined by performing multivariate analyses. Inclusion
Secondary Screening for pathologies known to be associated with a sensory disorder Screening questionnaires for Attention Deficit Hyperactivity Disorder (ADHD) will be distributed in order to identify disorders associated with a particular sensory profile. This will allow statistical results to be refined by performing multivariate analyses. Inclusion
Secondary Screening for pathologies known to be associated with a sensory disorder Screening questionnaires for Generalized Anxiety Disorder (GAD) will be distributed in order to identify disorders associated with a particular sensory profile. This will allow statistical results to be refined by performing multivariate analyses. Inclusion
Secondary Search for a link between the eating disorders severity and sensory disorders The EAT 26 questionnaire is used to measure the severity of an eating disorder. It will be proposed only to the participants of the eating disorder group.
This measure of severity will assess whether there is a relationship between the severity of the ED and the severity of the sensory disorders.
Inclusion
See also
  Status Clinical Trial Phase
Completed NCT04591886 - The Peer-Delivered "Mind. Body. Voice." Program for High School Women N/A
Completed NCT03097874 - Adaptive Treatment for Adolescent Anorexia Nervosa N/A
Completed NCT04591912 - The Peer-Delivered "Mind. Body. Voice." Program for High School Women (Mbv) - Remote N/A
Recruiting NCT06431854 - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program N/A
Completed NCT05554458 - Implementation and Evaluation of the ChildTaks+ Intervention in the Czech Republic N/A
Recruiting NCT04552639 - Evaluation of Compulsive Exercise Group Therapy for Eating Disorders N/A
Active, not recruiting NCT04127214 - The ITA Model of Integrated Treatment of Eating Disorders
Completed NCT04888273 - Assessing the Feasibility of an Intervention for Youth and Parents Transitioning to Adult Eating Disorder Services N/A
Recruiting NCT03563755 - Social Information Processing in Adolescents With Eating Disorders N/A
Active, not recruiting NCT05780242 - Recrudescence of Eating Conduct Disorders and Covid-19
Active, not recruiting NCT03693911 - ACT to Prevent Eating Disorders: Evaluating a Gamified Prevention Program N/A
Recruiting NCT03855553 - Project CORE: Disseminating Eating Disorders Treatment Phase 1
Completed NCT04088097 - Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating N/A
Completed NCT04263155 - The Peer-Delivered Body Project for Young Women in High School N/A
Completed NCT06039514 - Mobile App for Eating Disorders in Adolescents N/A
Enrolling by invitation NCT04869423 - Animal-Assisted Therapy in Adolescents With Eating Disorders N/A
Terminated NCT05073679 - Oral Naltrexone In Pediatric Eating Disorders Phase 2/Phase 3